I Trademark

Trademark Overview

On Thursday, December 5, 2019, a trademark application was filed for I with the United States Patent and Trademark Office. The USPTO has given the I trademark a serial number of 88716747. The federal status of this trademark filing is REGISTERED as of Tuesday, December 6, 2022. This trademark is owned by Idorsia Pharmaceuticals Ltd. The I trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention or treatment of neurological disorders, diseases and disorders of the central nervous system, sleep disorders
i

General Information

Serial Number88716747
Word MarkI
Filing DateThursday, December 5, 2019
Status700 - REGISTERED
Status DateTuesday, December 6, 2022
Registration Number6918716
Registration DateTuesday, December 6, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 7, 2020

Trademark Statements

Description of MarkThe mark consists of a stylized lower case "i" including an upper arm atop the stem. The dot of the "i" appears above the left part of the upper arm.
Goods and ServicesPharmaceutical preparations for the prevention or treatment of neurological disorders, diseases and disorders of the central nervous system, sleep disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 10, 2019
Primary Code005
First Use Anywhere DateWednesday, April 27, 2022
First Use In Commerce DateWednesday, April 27, 2022

Trademark Owner History

Party NameIdorsia Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressAllschwil 4123
CH
Party NameIdorsia Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressAllschwil 4123
CH
Party NameIdorsia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressAllschwil 4123
CH

Trademark Events

Event DateEvent Description
Tuesday, December 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 6, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, October 29, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 28, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 10, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, August 26, 2022USE AMENDMENT FILED
Friday, September 9, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 26, 2022TEAS STATEMENT OF USE RECEIVED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 18, 2022SOU EXTENSION 4 GRANTED
Wednesday, May 18, 2022SOU EXTENSION 4 FILED
Wednesday, May 18, 2022TEAS EXTENSION RECEIVED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 22, 2021SOU EXTENSION 3 GRANTED
Monday, November 22, 2021SOU EXTENSION 3 FILED
Monday, November 22, 2021TEAS EXTENSION RECEIVED
Tuesday, May 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 21, 2021SOU EXTENSION 2 GRANTED
Friday, May 21, 2021SOU EXTENSION 2 FILED
Friday, May 21, 2021TEAS EXTENSION RECEIVED
Tuesday, November 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 13, 2020SOU EXTENSION 1 GRANTED
Friday, November 13, 2020SOU EXTENSION 1 FILED
Friday, November 13, 2020TEAS EXTENSION RECEIVED
Tuesday, June 2, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 18, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 4, 2020ASSIGNED TO LIE
Wednesday, February 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 14, 2020EXAMINER'S AMENDMENT ENTERED
Friday, February 14, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 14, 2020EXAMINERS AMENDMENT E-MAILED
Friday, February 14, 2020EXAMINERS AMENDMENT -WRITTEN
Saturday, February 8, 2020ASSIGNED TO EXAMINER
Thursday, December 19, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 19, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 11, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 10, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 9, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

disorders central nervous system sleep diseases pharmaceutical prevention treatment neurological